Literature DB >> 19340501

Ultrastructural characteristics of glucocorticoid-induced osteoporosis.

B Bouvard1, M Audran, E Legrand, D Chappard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19340501     DOI: 10.1007/s00198-009-0864-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  25 in total

1.  Bone microarchitecture in males with corticosteroid-induced osteoporosis.

Authors:  D Chappard; N Josselin; C Rougé-Maillart; E Legrand; M F Baslé; M Audran
Journal:  Osteoporos Int       Date:  2006-11-22       Impact factor: 4.507

2.  Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice.

Authors:  Wei Yao; Zhiqiang Cheng; Cheryl Busse; Aaron Pham; Mary C Nakamura; Nancy E Lane
Journal:  Arthritis Rheum       Date:  2008-06

3.  Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study.

Authors:  D Chappard; E Legrand; M F Basle; P Fromont; J L Racineux; A Rebel; M Audran
Journal:  J Bone Miner Res       Date:  1996-05       Impact factor: 6.741

Review 4.  Use of oral corticosteroids and risk of fractures.

Authors:  T P Van Staa; H G Leufkens; L Abenhaim; B Zhang; C Cooper
Journal:  J Bone Miner Res       Date:  2000-06       Impact factor: 6.741

5.  Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae.

Authors:  E Canalis
Journal:  Endocrinology       Date:  1983-03       Impact factor: 4.736

6.  Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice.

Authors:  Nancy E Lane; Wei Yao; Mehdi Balooch; Ravi K Nalla; Guive Balooch; Stefan Habelitz; John H Kinney; Lynda F Bonewald
Journal:  J Bone Miner Res       Date:  2005-11-14       Impact factor: 6.741

7.  Cortisol downregulates osteoblast alpha 1 (I) procollagen mRNA by transcriptional and posttranscriptional mechanisms.

Authors:  A M Delany; B Y Gabbitas; E Canalis
Journal:  J Cell Biochem       Date:  1995-03       Impact factor: 4.429

8.  Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss.

Authors:  Feng-Sheng Wang; Jih-Yang Ko; Da-Wei Yeh; Huei-Ching Ke; Hsing-Long Wu
Journal:  Endocrinology       Date:  2008-01-03       Impact factor: 4.736

9.  Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures.

Authors:  Peter Vestergaard; Lars Rejnmark; Leif Mosekilde
Journal:  Calcif Tissue Int       Date:  2008-04-15       Impact factor: 4.333

Review 10.  The biological roles of extracellular and intracytoplasmic glucocorticoids in skeletal cells.

Authors:  Dun Hong; Hai-Xiao Chen; Ren-Shan Ge; Ji-Cheng Li
Journal:  J Steroid Biochem Mol Biol       Date:  2008-07-04       Impact factor: 4.292

View more
  6 in total

Review 1.  Nuclear receptors in osteoclasts.

Authors:  Seyeon Bae; Steven Zeng; Kyung-Hyun Park-Min
Journal:  Curr Opin Pharmacol       Date:  2020-06-20       Impact factor: 5.547

2.  A case of severe osteomalacia secondary to phosphate diabetes in a renal transplant recipient.

Authors:  Johnny Sayegh; Jean-François Augusto; Daniel Chappard; Paolo Insalaco; Jean-François Subra
Journal:  Int Urol Nephrol       Date:  2012-09-19       Impact factor: 2.370

3.  Necrostatin-1 treatment inhibits osteocyte necroptosis and trabecular deterioration in ovariectomized rats.

Authors:  Hongwang Cui; Yongjun Zhu; Qiming Yang; Weikang Zhao; Shiyang Zhang; Ao Zhou; Dianming Jiang
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

4.  Glucocorticoid-induced bone loss is associated with abnormal intravertebral areal bone mineral density distribution.

Authors:  Louise I Manning; Andrew M Briggs; Sharon Van Doornum; Ashwini Kale; Susan Kantor; John D Wark
Journal:  Int J Endocrinol       Date:  2013-05-08       Impact factor: 3.257

5.  Multiscale alterations in bone matrix quality increased fragility in steroid induced osteoporosis.

Authors:  A Karunaratne; L Xi; L Bentley; D Sykes; A Boyde; C T Esapa; N J Terrill; S D M Brown; R D Cox; R V Thakker; H S Gupta
Journal:  Bone       Date:  2015-12-02       Impact factor: 4.398

Review 6.  GLUCOCORTICOID-INDUCED BONE DISEASE: MECHANISMS AND IMPORTANCE IN PEDIATRIC PRACTICE.

Authors:  Emanuel Sávio Cavalcanti Sarinho; Verônica Maria Pinho Pessoa Melo
Journal:  Rev Paul Pediatr       Date:  2017-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.